Return On Equity of Salarius Pharmaceuticals, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Salarius Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • Salarius Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -401%, a 186% decline year-over-year.
  • Salarius Pharmaceuticals, Inc. annual Return On Equity for 2024 was -213%, a 7.7% decline from 2023.
  • Salarius Pharmaceuticals, Inc. annual Return On Equity for 2023 was -198%, a 43% decline from 2022.
  • Salarius Pharmaceuticals, Inc. annual Return On Equity for 2022 was -138%, a 377% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Salarius Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -401% -261% -186% 01 Jul 2025 30 Sep 2025
Q2 2025 -556% -408% -274% 01 Apr 2025 30 Jun 2025
Q1 2025 -324% -172% -113% 01 Jan 2025 31 Mar 2025
Q4 2024 -213% -15% -7.7% 01 Oct 2024 31 Dec 2024
Q3 2024 -140% +97% +41% 01 Jul 2024 30 Sep 2024
Q2 2024 -149% +144% +49% 01 Apr 2024 30 Jun 2024
Q1 2024 -152% +42% +22% 01 Jan 2024 31 Mar 2024
Q4 2023 -198% -59% -43% 01 Oct 2023 31 Dec 2023
Q3 2023 -237% -139% -142% 01 Jul 2023 30 Sep 2023
Q2 2023 -293% -242% -471% 01 Apr 2023 30 Jun 2023
Q1 2023 -194% -152% -359% 01 Jan 2023 31 Mar 2023
Q4 2022 -138% -109% -377% 01 Oct 2022 31 Dec 2022
Q3 2022 -98% -72% -275% 01 Jul 2022 30 Sep 2022
Q2 2022 -51% -27% -109% 01 Apr 2022 30 Jun 2022
Q1 2022 -42% -16% -61% 01 Jan 2022 31 Mar 2022
Q4 2021 -29% +9% +23% 01 Oct 2021 31 Dec 2021
Q3 2021 -26% +19% +42% 01 Jul 2021 30 Sep 2021
Q2 2021 -24% +36% +60% 01 Apr 2021 30 Jun 2021
Q1 2021 -26% +51% +66% 01 Jan 2021 31 Mar 2021
Q4 2020 -38% +84% +69% 01 Oct 2020 31 Dec 2020
Q3 2020 -45% +213% +83% 01 Jul 2020 30 Sep 2020
Q2 2020 -61% -6467% -101% 01 Apr 2020 30 Jun 2020
Q1 2020 -77% -750% -111% 01 Jan 2020 31 Mar 2020
Q4 2019 -122% -264% -185% 01 Oct 2019 31 Dec 2019
Q3 2019 -258% -646% -167% 01 Jul 2019 30 Sep 2019
Q2 2019 6406% +6651% 01 Apr 2019 30 Jun 2019
Q1 2019 674% +816% 01 Jan 2019 31 Mar 2019
Q4 2018 143% +248% 01 Oct 2018 31 Dec 2018
Q3 2018 387% +459% 01 Jul 2018 30 Sep 2018
Q2 2018 -245% -181% -282% 01 Apr 2018 30 Jun 2018
Q1 2018 -143% -82% -136% 01 Jan 2018 31 Mar 2018
Q4 2017 -106% -50% -91% 01 Oct 2017 31 Dec 2017
Q3 2017 -71% -22% -43% 01 Jul 2017 30 Sep 2017
Q2 2017 -64% -22% -51% 01 Apr 2017 30 Jun 2017
Q1 2017 -60% -26% -75% 01 Jan 2017 31 Mar 2017
Q4 2016 -56% -27% -93% 01 Oct 2016 31 Dec 2016
Q3 2016 -50% -17% -52% 01 Jul 2016 30 Sep 2016
Q2 2016 -42% 01 Apr 2016 30 Jun 2016
Q1 2016 -35% 01 Jan 2016 31 Mar 2016
Q4 2015 -29% 01 Oct 2015 31 Dec 2015
Q3 2015 -33% 01 Jul 2015 30 Sep 2015

Salarius Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -213% -15% -7.7% 01 Jan 2024 31 Dec 2024
2023 -198% -59% -43% 01 Jan 2023 31 Dec 2023
2022 -138% -109% -377% 01 Jan 2022 31 Dec 2022
2021 -29% +9% +23% 01 Jan 2021 31 Dec 2021
2020 -38% +84% +69% 01 Jan 2020 31 Dec 2020
2019 -122% -214% -232% 01 Jan 2019 31 Dec 2019
2018 92% +198% 01 Jan 2018 31 Dec 2018
2017 -106% -50% -91% 01 Jan 2017 31 Dec 2017
2016 -56% -27% -93% 01 Jan 2016 31 Dec 2016
2015 -29% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.